Bmkgene Amea

Biomarker Technologies(BMK), as one of the leading providers of genomics services, is founded in 2009, headquartered in Beijing, China. BMK has been actively engaged in the innovation and development of high-throughput sequencing technologies and bioinformatics for over 12 years. Its business consists of science and technology services, medical technology services and BioCloud bioinformatics platform. BMK has established long-term cooperation with various organizations, including universities, hospitals, research institutes, independent laboratories, pharmaceutical companies, plant breeding companies, medical and health institutes, etc, sitting in over 50 regions all over the world.